Eulav Asset Management Zoetis Inc. Transaction History

Eulav Asset Management

$4.11 Billion
Q3 2024

A detailed history of Eulav Asset Management transactions in Zoetis Inc. stock. As of the latest transaction made, Eulav Asset Management holds 125,000 shares of ZTS stock, worth $20.7 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

125,000

Previous 125,000 -0.0%

Holding current value

$20.7 Million

Previous $21.7 Million 12.7%

% of portfolio

0.59%

Previous 0.59%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $218,310 - $268,245	-1,500 Reduced 1.19%	125,000 $21.7 Million
Q1 2024 May 30, 2024	SELL	$165.67 - $199.94 $82,835 - $99,970	-500 Reduced 0.39%	126,500 $21.4 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $454,320 - $600,270	-3,000 Reduced 2.31%	127,000 $25.1 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $10.9 Million - $12.5 Million	65,000 Added 100.0%	130,000 $22.6 Million
Q2 2023 Aug 09, 2023	BUY	$160.94 - $186.23 $5.63 Million - $6.52 Million	35,000 Added 116.67%	65,000 $11.2 Million
Q1 2023 Apr 27, 2023	BUY	$145.48 - $175.02 $727,400 - $875,100	5,000 Added 20.0%	30,000 $4.99 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $131,140 - $157,470	-1,000 Reduced 3.85%	25,000 $3.66 Million
Q2 2022 Jul 22, 2022	BUY	$155.97 - $200.09 $4.06 Million - $5.2 Million	26,000 New	26,000 $4.47 Million
Q2 2021 Aug 06, 2021	SELL	$155.9 - $187.99 $3.59 Million - $4.33 Million	-23,009 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$144.0 - $169.39 $576,864 - $678,576	-4,006 Reduced 14.83%	23,009 $3.62 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $2,356 - $2,615	15 Added 0.06%	27,015 $4.47 Million
Q3 2020 Nov 05, 2020	SELL	$137.1 - $165.37 $278,724 - $336,197	-2,033 Reduced 7.0%	27,000 $4.47 Million
Q2 2020 Aug 11, 2020	SELL	$111.92 - $142.53 $3.36 Million - $4.28 Million	-30,060 Reduced 50.87%	29,033 $3.98 Million
Q1 2020 Apr 27, 2020	BUY	$92.66 - $144.94 $2.33 Million - $3.64 Million	25,093 Added 73.8%	59,093 $6.96 Million
Q4 2019 Feb 13, 2020	SELL	$116.25 - $133.25 $348,750 - $399,750	-3,000 Reduced 8.11%	34,000 $4.5 Million
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $4.17 Million - $4.75 Million	37,000 New	37,000 $4.61 Million
Q2 2019 Aug 05, 2019	SELL	$97.98 - $114.28 $3.92 Million - $4.57 Million	-40,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $79,280 - $95,270	-1,000 Reduced 2.44%	40,000 $3.42 Million
Q3 2018 Oct 26, 2018	SELL	$83.5 - $93.23 $83,500 - $93,230	-1,000 Reduced 2.38%	41,000 $3.75 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $159,800 - $178,400	-2,000 Reduced 4.55%	42,000 $3.58 Million
Q1 2018 May 09, 2018	SELL	$71.51 - $84.69 $214,530 - $254,070	-3,000 Reduced 6.38%	44,000 $3.67 Million
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $189,720 - $218,400	-3,000 Reduced 6.0%	47,000 $3.39 Million
Q3 2017 Nov 14, 2017	SELL	$59.73 - $65.4 $119,460 - $130,800	-2,000 Reduced 3.85%	50,000 $3.19 Million
Q2 2017 Aug 14, 2017	BUY	N/A	52,000	52,000 $3.24 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

411M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.

Account

Eulav Asset Management Zoetis Inc. Transaction History